ASMB
ASSEMBLY BIOSCIENCES, INC.Company Information
- Company Name
- ASSEMBLY BIOSCIENCES, INC.
- CIK
- CIK0001426800
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- ASMB: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ASMB
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-08-08
- Last sale
- 2026-06-17
- Shares purchased (TTM)
- 2,295,920
- Shares sold (TTM)
- 554
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 18,711,447
- Shares outstanding
- 18,853,646
- Ownership
- 99.25%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- 22.20%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 32 | 31 | 58 | 23 | 24 | 23 | 38 | 28 | 19 | 19 | 20 | 27 | ||||||
| Available For Sale Securities Debt Securities Current | 288 | 195 | 190 | 210 | 51 | 68 | 74 | 67 | 90 | 94 | 110 | 20 | ||||||
| Accounts Receivable Net Current | 1 | 0 | 1 | 1 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 7 | 6 | 5 | 3 | 2 | 4 | 3 | 3 | 4 | 4 | 3 | 3 | ||||||
| Assets Current | 328 | 233 | 255 | 237 | 77 | 96 | 116 | 98 | 113 | 117 | 134 | 50 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Operating Lease Right Of Use Asset | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 1 | 2 | 2 | 2 | 1 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Assets | 331 | 236 | 258 | 240 | 81 | 99 | 119 | 100 | 115 | 120 | 137 | 52 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | ||||||
| Other Accrued Liabilities Current | 3 | 3 | 8 | 6 | 3 | 2 | 7 | 5 | 4 | 2 | 6 | 4 | ||||||
| Contract With Customer Liability Current | 16 | 29 | 37 | 42 | 41 | 41 | 38 | 33 | 33 | 33 | 31 | - | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities Current | 23 | 35 | 49 | 53 | 47 | 47 | 48 | 42 | 41 | 39 | 39 | 7 | ||||||
| Contract With Customer Liability Noncurrent | - | - | 0 | 2 | 13 | 23 | 35 | 33 | 39 | 48 | 55 | 3 | ||||||
| Operating Lease Liability Noncurrent | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 0 | 0 | 1 | 1 | 0 | ||||||
| Liabilities | 25 | 37 | 51 | 57 | 63 | 72 | 86 | 74 | 81 | 87 | 96 | 10 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 1,151 | 1,040 | 1,039 | 1,037 | 863 | 862 | 859 | 842 | 841 | 828 | 827 | 817 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -845 | -841 | -832 | -854 | -845 | -835 | -826 | -816 | -806 | -795 | -786 | -775 | ||||||
| Stockholders Equity | 306 | 199 | 207 | 183 | 18 | 27 | 33 | 26 | 35 | 33 | 41 | 42 | ||||||
| Liabilities And Stockholders Equity | 331 | 236 | 258 | 240 | 81 | 99 | 119 | 100 | 115 | 120 | 137 | 52 | ||||||
| Related Party | - | - | - | - | - | - | - | - | - | - | 31 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | ||||||
| Common Stock Shares Issued | 20 | 16 | 16 | 16 | 8 | 8 | 7 | 6 | 6 | 5 | 5 | 4 | ||||||
| Shares Outstanding | 20 | 16 | 16 | 16 | 8 | 8 | 7 | 6 | 6 | 5 | 5 | 4 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialASSEMBLY BIOSCIENCES, INC. (ASMB) — SEC Financial Statements & Analysis
ASSEMBLY BIOSCIENCES, INC. (ASMB) is a pharmaceutical preparations company, incorporated in DE. ASSEMBLY BIOSCIENCES, INC. trades on Nasdaq as: ASMB. ASSEMBLY BIOSCIENCES, INC. (ASMB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, ASSEMBLY BIOSCIENCES, INC. carries a market cap of $518.10M, a P/E ratio of -12335.67x, a P/B ratio of 1.70x, a P/S ratio of 16.00x, an enterprise value of $485.81M, and an EV/EBITDA multiple of -55.92x. On profitability, it posts an operating margin of -27.17%, a net margin of -0.13%, a Return on Equity (ROE) of -0.03%, a Return on Assets (ROA) of -0.02%, and a Return on Invested Capital (ROIC) of -6.55%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $-2.05, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -2.62% year-over-year, net income growth of -99.89% year-over-year, and EPS growth of -99.96% year-over-year. On the balance sheet, it maintains a current ratio of 13.99x, a quick ratio of 13.70x, working capital of $304.53M, a debt-to-equity ratio of 0.08x, a debt ratio of 0.08, free cash flow of $-38.57M (TTM), and net debt of $-32.29M. Figures sourced from SEC EDGAR.
- Market Cap
- $518.10M
- P/E TTM
- -12335.67x
- EPS TTM
- $-0.00
- P/B TTM
- 1.70x
- ROE TTM
- -0.03%
- ROA TTM
- -0.02%
- Debt To Equity
- 0.08x
- Free Cash Flow TTM
- $-38.57M
- Net Revenue TTM Growth 1Y
- -2.62%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ASSEMBLY BIOSCIENCES, INC. in?
ASSEMBLY BIOSCIENCES, INC. (ASMB) operates in the Pharmaceutical Preparations industry.
What exchange does ASMB trade on?
ASSEMBLY BIOSCIENCES, INC. (ASMB) trades on the Nasdaq.
Where is ASSEMBLY BIOSCIENCES, INC. incorporated?
ASSEMBLY BIOSCIENCES, INC. is incorporated in DE.
When was ASSEMBLY BIOSCIENCES, INC. (ASMB)'s most recent SEC filing?
ASSEMBLY BIOSCIENCES, INC. (ASMB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is ASMB's market cap?
ASSEMBLY BIOSCIENCES, INC. (ASMB) has a market capitalization of $518.10M as of 2026-06-30.
What is ASMB's EPS (earnings per share)?
ASSEMBLY BIOSCIENCES, INC. (ASMB)'s trailing twelve month EPS is $-0.00 as of 2026-06-30.
What is ASMB's ROE (return on equity)?
ASSEMBLY BIOSCIENCES, INC. (ASMB)'s trailing twelve month Return on Equity (ROE) is -0.03% as of 2026-06-30.
What is ASMB's ROA (return on assets)?
ASSEMBLY BIOSCIENCES, INC. (ASMB)'s trailing twelve month Return on Assets (ROA) is -0.02% as of 2026-06-30.
What is ASMB's ROIC (return on invested capital)?
ASSEMBLY BIOSCIENCES, INC. (ASMB)'s trailing twelve month Return on Invested Capital (ROIC) is -6.55% as of 2026-06-30.
What is ASMB's EV/EBITDA?
ASSEMBLY BIOSCIENCES, INC. (ASMB)'s trailing twelve month EV/EBITDA is -55.92x as of 2026-06-30.